MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Cleanliness in Hospitals: Clinical Priority and Community Perception
EVS managers and communities value cleanliness for complementary reasons: managers for safety and compliance, communities for trust and comfort.
Dana-Farber Receives $50M Gift for Planned Cancer Hospital
A $50 million grant from the Yawkey Foundation will support construction of Dana-Farber Cancer Institute’s planned 450,000-square-foot cancer hospital.
Clarinda Regional Health Center Reports Data Security Incident
On or around December 15, 2025, Clarinda learned that certain data within its network may have been accessed without authorization.
Gaps in Nurses' Environmental Cleaning Knowledge Grow Amid Rising EVS Pressures
Environmental cleaning is crucial in preventing HAIs, but when the responsibility falls to those outside of EVS teams, problems arise.
Ground Broken on the Southern Nevada Forensic Facility
Construction on the new secure forensic psychiatric hospital is expected to be completed in 2029.